KOSPI · Healthcare · ₩135B
₩7,040-0.71%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.7% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“백신 판매 기반을 넓혀 다음 성장 발판을 마련했어요.”
In the company's words · 2026 2분기 filing